Doxofylline structure
|
Common Name | Doxofylline | ||
---|---|---|---|---|
CAS Number | 69975-86-6 | Molecular Weight | 266.253 | |
Density | 1.6±0.1 g/cm3 | Boiling Point | 505.2±53.0 °C at 760 mmHg | |
Molecular Formula | C11H14N4O4 | Melting Point | 144-146ºC | |
MSDS | USA | Flash Point | 259.3±30.9 °C | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of DoxofyllineDoxofylline is an antagonist of adenosine A1 receptor which also inhibits phosphodiesterase IV. |
Name | 7-(1,3-dioxolan-2-ylmethyl)-1,3-dimethylpurine-2,6-dione |
---|---|
Synonym | More Synonyms |
Description | Doxofylline is an antagonist of adenosine A1 receptor which also inhibits phosphodiesterase IV. |
---|---|
Related Catalog | |
Target |
Adenosine A1 receptor, phosphodiesterase IV[1] |
References |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 505.2±53.0 °C at 760 mmHg |
Melting Point | 144-146ºC |
Molecular Formula | C11H14N4O4 |
Molecular Weight | 266.253 |
Flash Point | 259.3±30.9 °C |
Exact Mass | 266.101501 |
PSA | 80.28000 |
LogP | -0.70 |
Vapour Pressure | 0.0±1.3 mmHg at 25°C |
Index of Refraction | 1.700 |
Water Solubility | Soluble |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302 |
Precautionary Statements | P301 + P312 + P330 |
Hazard Codes | Xi |
Risk Phrases | R36/37/38 |
Safety Phrases | S26-S36/37 |
RIDADR | NONH for all modes of transport |
Doxofylline, an antiasthmatic drug lacking affinity for adenosine receptors.
Arch. Int. Pharmacodyn. Ther. 295 , 221-37, (1988) In the present study the interaction of doxofylline, a new antiasthmatic drug, with A1- and A2-adenosine receptors of the guinea-pig brain and rat striatum was investigated in comparison with known me... |
|
Doxofylline in rat brain in relation to locomotor activity.
Drug Metab. Dispos. 17(4) , 437-40, (1989) Doxofylline is a new xanthine derivative with significant bronchodilatatory activity. We have studied in HPLC the distribution of doxofylline in various areas of rat brain (cortex, cerebellum, limbic ... |
|
The effect of intravenous doxofylline or aminophylline on gastric secretion in duodenal ulcer patients.
Aliment. Pharmacol. Ther. 4(6) , 643-9, (1990) The aim of this study was to compare the effects upon gastric secretion of therapeutic doses of aminophylline, with doxofylline, a new xanthine derivative proposed for the treatment of chronic asthma.... |
Maxivent |
Doxofilina [INN-Spanish] |
Doxofylline |
1H-Purine-2,6-dione, 7-(1,3-dioxolan-2-ylmethyl)-3,7-dihydro-1,3-dimethyl- |
Ansimar |
7-(1,3-Dioxolan-2-ylmethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione |
Ventax |
Doxofyllinum [INN-Latin] |
7-(1,3-dioxolan-2-ylmethyl)theophylline |
doxophylline |
EINECS 274-239-6 |
ABC 12/3 |
Dioxyfilline |
2-(7'-theophyllinemethyl)-1,3-dioxolane |
7-(1,3-Dioxolan-2-ylmethyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione |
7-(1,3-dioxolan-2-yl-methyl)3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione |
MFCD00865218 |